Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients

ConclusionPKM2 is an independent prognostic factor for survival and is associated with poor prognosis in GBM patients treated with radiotherapy. It may be a potential therapeutic target for anticancer therapy.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research